Justin Zelin analyst BTIG

Currently out of the existing stock ratings of Justin Zelin, 45 are a BUY (93.75%), 3 are a HOLD (6.25%).

Justin Zelin

Work Performance Price Targets & Ratings Chart

Analyst Justin Zelin, currently employed at BTIG, carries an average stock price target met ratio of 24.51% that have a potential upside of 42.34% achieved within 107 days.

Justin Zelin’s has documented 85 price targets and ratings displayed on 19 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on VKTX, Viking Therapeutics at 22-Sep-2025.

Wall Street Analyst Justin Zelin

Analyst best performing recommendations are on LYRA (LYRA THERAPEUTICS ).
The best stock recommendation documented was for ABEO (ABEONA THERAPEUTICS) at 11/11/2020. The price target of $50 was fulfilled within 69 days with a profit of $17.5 (53.85%) receiving and performance score of 7.8.

Average potential price target upside

ABEO Abeona Therapeutics ACET Adicet Bio BLU BELLUS Health LEGN Legend Biotech Corp MBIO Mustang Bio CASI CASI Pharmaceuticals PSTX Poseida Therapeutics SURF Surface Oncology MEIP MEI Pharma VKTX Viking Therapeutics ETN Eaton PLC ETNB 89bio IMCR Immunocore Holdings Ltd GRCL Gracell Biotechnologies DTIL Precision BioSciences JSPR Jasper Therapeutics VSTM Verastem LYRA Lyra Therapeutics  PROK ProKidney Corp.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$20

$14.59 (269.69%)

$20

1 months 23 days ago
(17-Aug-2025)

0/9 (0%)

$13.09 (189.44%)

Buy

$20

$14.59 (269.69%)

$19

1 months 26 days ago
(14-Aug-2025)

0/2 (0%)

$12.87 (180.50%)

Buy

$20

$14.59 (269.69%)

$21

4 months 25 days ago
(15-May-2025)

0/2 (0%)

$13.9 (227.87%)

Buy

$15

$9.59 (177.26%)

$15

6 months 17 days ago
(23-Mar-2025)

0/2 (0%)

$9.88 (192.97%)

Buy

$18

$12.59 (232.72%)

$18

11 months 12 days ago
(28-Oct-2024)

1/5 (20%)

$11.43 (173.97%)

61

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Justin Zelin is most bullish on?

Potential upside of $95.28 has been obtained for VKTX (VIKING THERAPEUTICS)

Which stock is Justin Zelin is most reserved on?

Potential downside of $4.53 has been obtained for JSPR (JASPER THERAPEUTICS)

What Year was the first public recommendation made by Justin Zelin?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?